a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
Published 1 year ago • 130 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
1:52
results of phase i study of mcl-1 inhibition with azd5991 in r/r hematologic malignancies
-
9:15
acute myeloid leukemia (all) mnemonic| usmle step nclex comlex
-
9:25
mgus diagnosis: a step-by-step approach
-
4:54
beakertv | meet brenda montgomery, msl at biomea fusion
-
1:44
insights into the phase ii tidal study
-
1:45
a phase ii study of elritercept for lower-risk mds
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
4:03
a phase i/ii study evaluating quizartinib plus decitabine and venetoclax in flt3-mutated aml
-
1:17
phase ii study of tosedostat in mds
-
1:34
single-center study evaluating the outcomes of patients with aml who relapsed after allosct
-
2:41
a phase i/ii study of afm13 in combination with cord blood-derived nk cells in patients with r/r hl
-
1:18
beat aml master sub-study: enasidenib and response-driven addition of azacitidine in idh2m aml
-
3:21
a phase i trial of hu8f4, an anti-pr1/hla-a2 monoclonal antibody, in r/r myeloid malignancies
-
1:25
insights into a phase ii study evaluating anx005 in waiha
-
3:10
phase ii study of all-oral aaa regimen for patients with newly diagnosed apl
-
2:45
continuity of care for patients with hematological predispositions to aml
-
1:28
the role of allogeneic transplantation in patients with aml in the frontline setting
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml